↓ Skip to main content

American Association for Cancer Research

Article Metrics

CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Preestablished Immunity

Overview of attention for article published in Blood Cancer Discovery, January 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#13 of 128)
  • High Attention Score compared to outputs of the same age (96th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

news
1 news outlet
twitter
107 tweeters

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
9 Mendeley